Empagliflozin improves Cognitive impairment in Frail Diabetics with HFpEF
Empagliflozin improves Cognitive impairment in Frail Diabetics with HFpEF Italy: Empagliflozin a SGLT2 inhibitor improves the cognitive and Physical impairment in frail older adults Heart failure with Preserved Ejection Fraction and Type 2 Diabetes a recent study has found. It is to be noted that this study was published in Journal Diabetes care on March […]
Diabetes and Endocrinology